Stockscreener 앱 받기
9.10
4.44%
0.43
전일 마감가:
$8.67
열려 있는:
$8.79
하루 거래량:
2.24M
Relative Volume:
0.23
시가총액:
$1.06B
수익:
$829.22M
순이익/손실:
$-248.96M
주가수익비율:
-30.33
EPS:
-0.3
순현금흐름:
$-92.10M
1주 성능:
-6.75%
1개월 성능:
-13.10%
6개월 성능:
+15.22%
1년 성능:
-19.87%
1일 변동 폭
$8.76
$9.18
1주일 범위
$8.61
$9.6799
52주 변동 폭
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
명칭
Tilray Brands Inc
전화
519.322.8800
주소
655 MADISON AVENUE, NEW YORK
TLRY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
9.0925 | 1.01B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
125.06 | 55.12B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.02 | 50.80B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.27 | 45.60B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.84 | 36.04B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
468.12 | 20.23B | 3.08B | 1.24B | 1.07B | 25.61 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-05 | 재확인 | Alliance Global Partners | Neutral |
| 2022-11-02 | 개시 | Bernstein | Mkt Perform |
| 2022-07-29 | 다운그레이드 | The Benchmark Company | Hold → Sell |
| 2022-03-04 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | 개시 | Barclays | Underweight |
| 2021-11-01 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | 다운그레이드 | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | 재개 | Cowen | Outperform |
| 2021-05-07 | 재개 | Jefferies | Buy |
| 2021-05-06 | 개시 | Canaccord Genuity | Buy |
| 2021-04-28 | 재개 | BofA Securities | Buy |
| 2021-02-18 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-11-16 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-11-11 | 다운그레이드 | Stifel | Hold → Sell |
| 2020-10-01 | 재확인 | MKM Partners | Neutral |
| 2020-09-21 | 업그레이드 | Jefferies | Underperform → Hold |
| 2020-05-12 | 재확인 | The Benchmark Company | Buy |
| 2020-04-16 | 다운그레이드 | Jefferies | Hold → Underperform |
| 2020-04-09 | 다운그레이드 | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-13 | 개시 | BofA/Merrill | Neutral |
| 2019-11-13 | 재확인 | The Benchmark Company | Buy |
| 2019-11-05 | 개시 | Cantor Fitzgerald | Neutral |
| 2019-10-22 | 재확인 | Piper Jaffray | Overweight |
| 2019-09-20 | 개시 | MKM Partners | Neutral |
| 2019-08-14 | 재확인 | The Benchmark Company | Buy |
| 2019-07-17 | 개시 | Ladenburg Thalmann | Neutral |
| 2019-06-28 | 개시 | Consumer Edge Research | Overweight |
| 2019-06-06 | 개시 | Stifel | Hold |
| 2019-06-05 | 개시 | Oppenheimer | Perform |
| 2019-05-15 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | 개시 | Alliance Global Partners | Neutral |
모두보기
Tilray Brands Inc 주식(TLRY)의 최신 뉴스
What's Going On With Tilray Stock Today? - Benzinga
Tilray (TLRY) Expands Medical Cannabis Operations in Italy - GuruFocus
New 9% 'Big Trip' IPA rides Southeast double-IPA demand - Stock Titan
Tilray Medical Launches Tilray Medical Italia, Expanding Presence in Italy's Medical Cannabis Market - Quiver Quantitative
Tilray brings prescription cannabis oils and flower to Italian patients - Stock Titan
Promising Cannabis Stocks To Watch TodayJanuary 21st - MarketBeat
Tilray’s Financial Turnaround: Losses Narrow Amidst Strategic Shifts - AD HOC NEWS
Tilray Brands Just Posted Record Numbers for Q2. Is the Stock a Buy? - AOL.com
Tilray Brands (NASDAQ:TLRY) Trading Down 7.4% Following Analyst Downgrade - MarketBeat
Tilray Brands (TLRY): Roth Capital Lowers Price Target to $10 | - GuruFocus
Tilray Brands (NASDAQ:TLRY) Given New $10.00 Price Target at Roth Capital - MarketBeat
Mixed Signals for Tilray: Record Revenue Meets Analyst Caution - AD HOC NEWS
How Tilray Brands Is Acting on Its Vast International Opportunity - The Globe and Mail
Tilray Brands Reports $218 Million Q2 Revenue, Market Reacts Positively - Intellectia AI
Tilray Brands, Inc. (NASDAQ:TLRY) Given Consensus Rating of "Reduce" by Brokerages - MarketBeat
This Beaten-Down Stock Just Posted Record Revenue. Is It Finally Time to Buy? - Finviz
Top Cannabis Stocks To Follow TodayJanuary 19th - MarketBeat
Tilray’s Mixed Quarter: Record Revenue Overshadowed by Widening Losses - AD HOC NEWS
Tilray. Buy, Sell or Hold? - Cantech Letter
Trump's Cannabis Rescheduling Order Could Finally Kill A Crushing Tax Rule And Transform US Weed Stocks, Says Expert - Benzinga
Tilray Shares Face Headwinds Following Quarterly Report - AD HOC NEWS
Tilray Shares Face Mounting Investor Skepticism Despite Revenue Gains - AD HOC NEWS
Promising Cannabis Stocks To Keep An Eye OnJanuary 18th - MarketBeat
Tilray’s Financial Paradox: Record Revenue Amid Persistent Losses - AD HOC NEWS
Best Cannabis Stocks To ResearchJanuary 17th - MarketBeat
Tilray’s Financial Results Reveal Deepening Concerns for Investors - AD HOC NEWS
Tilray anticipates $150M global medical cannabis revenue run rate as international expansion accelerates - MSN
Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.6%Time to Sell? - MarketBeat
Top Cannabis Stocks To Add to Your WatchlistJanuary 16th - MarketBeat
Promising Cannabis Stocks To Add to Your WatchlistJanuary 3rd - MarketBeat
Village Farms Stock More Than Doubles in 6 Months: How to Play? - The Globe and Mail
Lacklustre Performance Is Driving Tilray Brands, Inc.'s (NASDAQ:TLRY) 30% Price Drop - simplywall.st
Tilray’s Profitability Concerns Overshadow Record Revenue - AD HOC NEWS
Tilray Continues to Gain in Canada and International Medical, but We're Skeptical of US Prospects - Morningstar
Tilray Brands (NASDAQ:TLRY) Shares Down 1.9%What's Next? - MarketBeat
Best Cannabis Stocks To Watch TodayJanuary 15th - MarketBeat
Tilray Brands (NASDAQ:TLRY) Downgraded to "Strong Sell" Rating by Zacks Research - MarketBeat
Tilray Brands (NASDAQ:TLRY) Trading Up 5.4%Here's What Happened - MarketBeat
Cannabis Stocks To Watch TodayJanuary 14th - MarketBeat
Tilray Posts Record Revenue Amid Diverging Segment Performance - AD HOC NEWS
What's Next for Tilray Brands After Posting Record Q2 Revenues? - The Globe and Mail
Tilray Brands (TSX:TLRY) Price Target Decreased by 18.79% to 19.17 - Nasdaq
Investment Recap: Why Tilray Brands Inc stock is seen as undervaluedJuly 2025 Summary & Detailed Earnings Play Alerts - moha.gov.vn
Top Cannabis Stocks To ResearchJanuary 13th - MarketBeat
Best Cannabis Stocks To Follow TodayJanuary 8th - MarketBeat
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings? - The Globe and Mail
Legal Cannabis Market Set for Dynamic Growth with Key Players Aurora Cannabis • Cronos Group • Tilray Brands - openPR.com
This Under-$10 Growth Stock May Be Better Positioned Than Investors Realize - Barchart.com
Tilray Brands (XTRA:2HQ) Price Target Decreased by 23.26% to 11.31 - Nasdaq
Tilray Reports Historic Quarterly Revenue Amid Strategic Shifts - AD HOC NEWS
Tilray Brands (NASDAQ:TLRY) Shares Up 1.3%Still a Buy? - MarketBeat
Tilray Brands Inc (TLRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tilray Brands Inc 주식 (TLRY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SIMON IRWIN D | President and CEO |
Jul 31 '25 |
Option Exercise |
0.58 |
706,216 |
409,605 |
5,200,788 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
3.61%
0.37%
자본화:
|
볼륨(24시간):